Intravitreal Anti-VEGF Therapy for Exudative Age-Related Macular Degeneration in the Presence of Significant Macular Pucker

被引：0
|
作者：
Chaudhry, N. A. [1 ]
Jara, V. A. Kon [1 ]
Tabandeh, H. [2 ]
Mieler, W. F. [3 ]
Liggett, P. E. [4 ]
机构：
[1] New England Retina Associates, Retina, Hamden, CT USA
[2] Vitreous Retina Associates, Retina, Beverly Hills, CA USA
[3] Univ Illinois, Ophthalmol, Chicago, IL USA
[4] New England Retina Associates, Ophthalmol, Hamden, CT USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
macula/fovea; choroid: neovascularization; retina;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
550
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Safety of intravitreal pegcetacoplan inpatients with neovascular age-related macular degeneration receiving anti-VEGF therapy
    Hu, Allen
    Esmaili, Daniel
    Ribiero, Ramiro
    Bliss, Caleb
    Jones, Daniel
    Brown, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [22] Visual acuity and progression of macular atrophy in patients receiving intravitreal anti-VEGF for age-related macular degeneration
    Ji, Marco H.
    Callaway, Natalia F.
    Ludwig, Cassie A.
    Vail, Daniel
    Al-Moujahed, Ahmad
    Rosenblatt, Tatiana R.
    Leng, Theodore
    Sanislo, Steven R.
    Moshfeghi, Darius M.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (01) : 429 - 435
  • [23] Long-standing exudative age-related macular degeneration and anti-vegf treatment response
    Leite, Angelo Carvalho
    Amaro, Miguel
    Nassaralla, Arthur
    Damasceno, Nadyr Antonia
    Nassaralla, Joao J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [24] Anti-VEGF therapies for the treatment of age-related macular degeneration
    Gower, Emily W.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2012, 1 (06) : 485 - 488
  • [25] Neovascular age-related macular degeneration and anti-VEGF nonresponders
    Sheybani, Arsham
    Almony, Arghavan
    Blinder, Kevin J.
    Shah, Gaurav K.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2010, 5 (01) : 35 - 41
  • [26] Circulating antiretinal antibodies predict the outcome of anti-VEGF therapy in patients with exudative age-related macular degeneration
    Kubicka-Trzaska, Agnieszka
    Wilanska, Joanna
    Romanowska-Dixon, Bozena
    Sanak, Marek
    ACTA OPHTHALMOLOGICA, 2012, 90 (01) : E21 - E24
  • [27] Comparative Safety and Tolerability of Anti-VEGF Therapy in Age-Related Macular Degeneration
    Modi, Yasha S.
    Tanchon, Carley
    Ehlers, Justis P.
    DRUG SAFETY, 2015, 38 (03) : 279 - 293
  • [28] Remission and dropout rate of anti-VEGF therapy for age-related macular degeneration
    Oishi, Akio
    Mandai, Michiko
    Nishida, Akihiro
    Hata, Masayuki
    Matsuki, Takaaki
    Kurimoto, Yasuo
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2011, 21 (06) : 777 - 782
  • [29] Comparative Safety and Tolerability of Anti-VEGF Therapy in Age-Related Macular Degeneration
    Yasha S. Modi
    Carley Tanchon
    Justis P. Ehlers
    Drug Safety, 2015, 38 : 279 - 293
  • [30] Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: Therapeutic Strategies
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 541 - 547
12345